Encephalomyelitis News and Research

RSS

Apoptosis is an important mediator of pathogenesis in animal coronavirus infection

A new paper in the journal Life presents an early review of the viral factors involved in initiating and effecting apoptosis within infected cells.

8 Mar 2021

Slight differences can help distinguish between two similar pediatric brain conditions

Slight differences in clinical features can help physicians distinguish between two rare but similar forms of autoimmune brain inflammation in children, a new study by UT Southwestern scientists suggests.

23 Feb 2021

Study maps SARS-CoV-2 infected brains

Researchers in the United States and Canada have mapped the presence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the brains of people who died from coronavirus disease 2019 (COVID-19).

21 Feb 2021

Some COVID-19 patients experience persistent chronic fatigue six months after infection, finds study

Scientists from Germany recently revealed that almost 50% of patients present with moderate to severe chronic fatigue syndrome six months after SARS-CoV-2 infection.

10 Feb 2021

Early-life-trauma could affect trajectory of multiple sclerosis development and treatment

Childhood trauma could affect the trajectory of multiple sclerosis development and response to treatment in adulthood, a new study in mice found.

29 Jan 2021

Study examines risk factors for developing ME/CFS in college students after infectious mononucleosis

Many college students fully recover from infectious mononucleosis (which is almost always caused by Epstein-Barr virus) within 1-6 weeks, but some go on to develop chronic fatigue syndrome, also called myalgic encephalomyelitis (ME/CFS).

22 Jan 2021

Myelin‐specific T cells implicated in central nervous system disease in monkeys

Scientists have uncovered new clues implicating a type of herpes virus as the cause of a central nervous system disease in monkeys that's similar to multiple sclerosis in people.

15 Jan 2021

No inflammation of cerebrospinal fluid in COVID-19 patients with neurological features, study finds

Many patients with COVID-19 have shown neurological complications, leading to scientific interest in the role played by its causative pathogen, SARS-CoV-2, in brain inflammation. A new study has described the absence of neuroinflammation in cerebrospinal fluid (CSF).

14 Jan 2021

New therapeutic approach brings hope for treating psoriasis

Disruptive innovations in psoriasis are leading the way at EADV's 29th Congress, EADV Virtual. New data published today shows the first clinical evidence of modulating systemic inflammation by oral delivery of a non-living single strain commensal microbe.

29 Oct 2020

Scientists discover key enzyme involved in the development of autoimmune diseases

Scientists affiliated with the Center for Research on Inflammatory Diseases (CRID http://crid.fmrp.usp.br), hosted by the University of São Paulo (USP) in Brazil, have discovered that an enzyme involved in key metabolic processes also plays a role in immune cell differentiation and hence in the development of autoimmune diseases.

19 Oct 2020

New therapy may help treat or prevent multiple sclerosis

Multiple sclerosis, an autoimmune disease of the central nervous system that affects millions worldwide, can cause debilitating symptoms for those who suffer from it.

13 Oct 2020

Home-based pediatric teleneuropsychology evaluations shown to be effective

Administering neuropsychology evaluations to children online in the comfort of their own homes is feasible and delivers results comparable to tests traditionally performed in a clinic, a new study led by UT Southwestern researchers and Children's Health indicates.

24 Sep 2020

Researchers explore clinical and biological aspects of myalgic encephalomyelitis/chronic fatigue syndrome

One of the major symptoms of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is post-exertional malaise (PEM), the worsening of symptoms after physical or mental activities.

23 Sep 2020

Reelin inhibition may be effective for treating multiple sclerosis

In an animal model of multiple sclerosis (MS), decreasing the amount of a protein made in the liver significantly protected against development of the disease's characteristic symptoms and promoted recovery in symptomatic animals, UTSW scientists report.

12 Aug 2020

Chronic fatigue syndrome and Gulf War illness produce different patterns of brain activity after moderate exercise

A brain imaging study of veterans with Gulf War illness (GWI) and patients with chronic fatigue syndrome (CFS) (sometimes called myalgic encephalomyelitis), has shown that the two illnesses produce distinctly different, abnormal patterns of brain activity after moderate exercise.

10 Aug 2020

U.K. to roll out the largest genetic study on chronic fatigue syndrome

Fatigue is the feeling of constant tiredness or weakness, which can affect anyone. In worse cases, people develop a condition called myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). This condition is debilitating and lacks a universally accepted definition, cause, diagnosis, and even treatment.

24 Jun 2020

Encephalomyelitis News and Research

Apoptosis is an important mediator of pathogenesis in animal coronavirus infection

Slight differences can help distinguish between two similar pediatric brain conditions

Study maps SARS-CoV-2 infected brains

Some COVID-19 patients experience persistent chronic fatigue six months after infection, finds study

Early-life-trauma could affect trajectory of multiple sclerosis development and treatment

Study examines risk factors for developing ME/CFS in college students after infectious mononucleosis

Myelin‐specific T cells implicated in central nervous system disease in monkeys

No inflammation of cerebrospinal fluid in COVID-19 patients with neurological features, study finds

New therapeutic approach brings hope for treating psoriasis

Scientists discover key enzyme involved in the development of autoimmune diseases

New therapy may help treat or prevent multiple sclerosis

Home-based pediatric teleneuropsychology evaluations shown to be effective

Researchers explore clinical and biological aspects of myalgic encephalomyelitis/chronic fatigue syndrome

Reelin inhibition may be effective for treating multiple sclerosis

Chronic fatigue syndrome and Gulf War illness produce different patterns of brain activity after moderate exercise

U.K. to roll out the largest genetic study on chronic fatigue syndrome

Integrin-binding peptide ATN-161: Potential COVID-19 treatment

New project could help healthcare providers plan for coronavirus consequences

Study: Certain inflammatory demyelinating diseases belong to different category than multiple sclerosis

French scientists suggest nicotinic agonists could treat COVID-19

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News